| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1995.TB03297.X |
| P698 | PubMed publication ID | 7873374 |
| P2093 | author name string | S Faderl | |
| B Emmerich | |||
| R Dengler | |||
| C Nerl | |||
| U Münstermann | |||
| I Hausner | |||
| S al-Batran | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | flow cytometry | Q1141429 |
| P304 | page(s) | 250-257 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells | |
| P478 | volume | 89 |
| Q98623678 | A newly isolated strain of Halomonas sp. (HA1) exerts anticancer potential via induction of apoptosis and G2/M arrest in hepatocellular carcinoma (HepG2) cell line |
| Q39340944 | AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia |
| Q64991393 | ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives. |
| Q34726045 | Adoptive transfer of T-cell immunity |
| Q47788832 | Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3. |
| Q34443802 | Characterization of chronic myeloid leukemia stem cells. |
| Q37132892 | Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation |
| Q74268543 | Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia |
| Q34207573 | Evolution of bone marrow transplantation--the original immunotherapy. |
| Q34350591 | FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes |
| Q35971029 | Immunotherapy targets in pediatric cancer |
| Q38015123 | Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. |
| Q40844407 | MCF-7 mammary tumour cells express the myeloid cell differentiation controlling factor, serine protease 3/myeloblastin |
| Q90320547 | Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation |
| Q34318010 | Molecules and mechanisms of the graft-versus-leukaemia effect |
| Q37110277 | Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells |
| Q35605318 | NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic ma |
| Q37495378 | Novel postremission strategies in adults with acute myeloid leukemia |
| Q33644438 | PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal |
| Q39631989 | PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia. |
| Q33929477 | Promising approaches in acute leukemia |
| Q28201442 | Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia |
| Q34560830 | Transcriptional mechanisms regulating myeloid-specific genes |
| Q36793112 | Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias |
| Q35909318 | Vaccines in leukemia. |
Search more.